Gujarat Terce Laboratories share news, announcements and annual reports
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Gujarat Terce Laboratories Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1993
Last close ₹41.12down ₹1.83 (4.26%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹42.95.
30 Oct: open ₹44.00, high ₹44.00, low ₹40.50
52-week range of traded prices to 30 Oct 2026
₹29.00Low, 30 Mar 2026₹50.00High, 13 Jan 2026
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹32 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.35
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 12.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.29
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 14,931
Gujarat Terce Laboratories board meetings
120 filed, newest first. Page 2 of 3.
Nov 2022
14 Nov · Board meeting
3 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Aug 2022
5 Aug · Board meeting
Jul 2022
27 Jul · Board meeting
Meeting on 5 Aug 2022: quarterly results
May 2022
30 May · Board meeting
19 May · Board meeting
Meeting on 30 May 2022: audited results
Jan 2022
17 Jan · Board meeting
Meeting on 24 Jan 2022: quarterly results
Oct 2021
20 Oct · Board meeting
Meeting on 28 Oct 2021: quarterly results
Jul 2021
15 Jul · Board meeting
Meeting on 23 Jul 2021: quarterly results
Jun 2021
24 Jun · Board meeting
18 Jun · Board meeting
Meeting on 24 Jun 2021: audited results
Mar 2021
22 Mar · Board meeting
Meeting on 30 Mar 2021
Feb 2021
1 Feb · Board meeting
Meeting on 5 Feb 2021: quarterly results
Jan 2021
Nov 2020
Oct 2020
29 Oct · Board meeting
Meeting on 7 Nov 2020: quarterly results
Aug 2020
8 Aug · Board meeting
Jul 2020
30 Jul · Board meeting
Meeting on 8 Aug 2020: quarterly results
Jun 2020
29 Jun · Board meeting
22 Jun · Board meeting
Meeting on 29 Jun 2020: audited results and quarterly results
Feb 2020
26 Feb · Board meeting
18 Feb · Board meeting
Meeting on 26 Feb 20205 Feb · Board meeting
Meeting on 13 Feb 2020: quarterly results
Jan 2020
Oct 2019
22 Oct · Board meeting
14 Oct · Board meeting
Meeting on 22 Oct 2019: quarterly results
Jul 2019
29 Jul · Board meeting
Meeting on 9 Aug 2019: quarterly results
May 2019
18 May · Board meeting
8 May · Board meeting
Meeting on 18 May 2019: audited results
Jan 2019
29 Jan · Board meeting
Meeting on 11 Feb 2019: quarterly results